Search

Your search keyword '"Geissler, K."' showing total 1,090 results

Search Constraints

Start Over You searched for: Author "Geissler, K." Remove constraint Author: "Geissler, K."
1,090 results on '"Geissler, K."'

Search Results

3. Resolving the L/T transition binary SDSS J2052-1609 AB

4. Lucky Imaging survey for southern M dwarf binaries

5. A different glance to the site testing above Dome C

6. Imaging search for the unseen companion to Eps Ind A -- Improving the detection limits with 4 micron observations

7. Mid-infrared imaging of brown dwarfs in binary systems

8. A direct and differential imaging search for sub-stellar companions to epsilon Indi A

9. Meteorologic parameters analysis above Dome C made with ECMWF data

10. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS

12. Treatment of recurrent acute tonsillitis-a systematic review and clinical practice recommendations.

13. P134 - Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS

15. Operative Behandlung der rezidivierenden akuten Tonsillitis: Tonsillektomie oder Tonsillotomie?

18. P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

19. P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECITABINE IN AML PATIENTS

20. PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)

22. Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures

23. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose

24. Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells

27. Das hämatopoetische System im Rahmen des Multiorganversagens

33. CHRONOS‐3: RANDOMIZED PHASE III STUDY OF COPANLISIB PLUS RITUXIMAB VS RITUXIMAB/PLACEBO IN RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (INHL)

39. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

40. Abstract CT001: CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL)

41. CHRONOS‐3: Randomized phase III study of copanlisib plus rituximab/placebo in relapsed indolent Non-Hodgkin Lymphoma (INHL)

43. Erratum to [German Guideline for Idiopathic Pulmonary Fibrosis]

44. Diagnostic yield of biopsy in corticosteroid pretreated patients with primary central nervous system lymphoma

Catalog

Books, media, physical & digital resources